Prolonged and late-onset symptoms of coronavirus disease 2019.
Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S, Hayakawa K, Ohmagari N.
Open Forum Infectious Diseases. 2020.
https://doi.org/10.1093/ofid/ofaa507
(2020/10/21)
Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
Nakamoto T, Ishikane M, Sasaki R, Ohmagari N.
Int J Infect Dis. 2020.
https://doi.org/10.1016/j.ijid.2020.10.029
(2020/10/17)
Environmental surface and air contamination in severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity.
Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, Suzuki T, Sugiki Y, Okuhama A, Kanda K, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Moriyama Y, Ota M, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Miyazato Y, Hayakawa K, Saito S, Ohmagari N.
Infection Prevention in Practice. 2020;2(4):100098.
https://doi.org/10.1016/j.infpip.2020.100098
(2020/10/13)
Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
Takaya S, Tsuzuki S, Hayakawa K, Kawashima A, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Nomoto H, Nakamoto T, Hikida S, Tanuma J, Ohara K, Ito T, Baba T, Yamamoto K, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Ohmagari N.
Epidemiol Infect. 2020;148:e250.
https://doi.org/10.1017/S0950268820002496
(2020/10/13)
▼Published in September 2020
Depressive symptoms in students during school closure due to COVID-19 in Shanghai.
Xiang M, Yamamoto S, Mizoue T.
Psychiatry Clin Neurosci. 2020.
https://doi.org/10.1111/pcn.13161
(2020/9/30)
Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki M, Saito Sho, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N.
Clinical Infectious Diseases. 2020. ciaa1470.
https://doi.org/10.1093/cid/ciaa1470
(2020/9/28)
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Kutsuna S, Asai Y, Matsunaga A.
N Engl J Med. 2020;383(17):1695-1696.
https://doi.org/10.1056/NEJMc2027051
(2020/9/23)
Strengthening public health response after COVID-19: Review of the Centers for Disease Control and Prevention of the United States to envision "Japan CDC".
Sugiyama T, Imai K, Higashi T, Tomio J, Tamiya N.
Japanese Journal of Public Health. 2020;67(9):567-572. Japanese.
https://doi.org/10.11236/jph.20-069
(2020/9/15)
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M.
Gene. 2020;766:145145.
https://doi.org/10.1016/j.gene.2020.145145
(2020/9/15)
Global health landscape challenges triggered by COVID-19.
Nakatani H, Katsuno K, Urabe H.
Inflamm Regen. 2020;40:34.
https://doi.org/10.1186/s41232-020-00144-5
(2020/9/14)
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.
Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y, Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M , Kinoshita N, Kutsuna S, Ohmagari N.
J Infect Chemother. 2020.
https://doi.org/10.1016/j.jiac.2020.09.006
(2020/9/9)
▼Published in August 2020
Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion.
Kusaba Y, Izumi S , Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M, Ohmagari N, Katano H, Suzuki T, Hojo M, Sugiyama H.
Internal Medicine. 2020;59(19):2405-2408.
https://doi.org/10.2169/internalmedicine.5413-20
(2020/8/29)
Shifting workstyle to teleworking as a new normal in face of COVID-19: analysis with the model introducing intercity movement and behavioral pattern.
Karako K, Song P, Chen Y, Tang W.
Ann Transl Med. 2020;8(17):1056.
http://dx.doi.org/10.21037/atm-20-5334
(2020/8/24)
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.
Hattori S-i, Higshi-Kuwata N, Raghavaiah J, Das D, Bulut H, Davis D, Takamatsu Y, Matsuda K, Takamune N, Kishimoto N, Okamura T, Misumi S, Yarchoan R, Maeda K, Ghosh A, Mitsuya H.
mBio. 2020;11:e01833-20.
https://doi.org/10.1128/mBio.01833-20
(2020/8/20)
Case of adult large vessel vasculitis after SARSCoV-2 infection.
Oda R, Inagaki T, Ishikane M, Hotta M, Shimomura A, Sato M, Nakamoto T, Akiyama Y, Yamamoto K, Minamimoto R, Kaneko H, Ohmagari N.
Ann Rheum Dis. 2020.
http://dx.doi.org/10.1136/annrheumdis-2020-218440
(2020/8/11)
Do the Asia and Oceania Federation of Obstetrics and Gynecology members' websites provide information targeting women in the context of the COVID‐19 pandemic?
Kikuchi S, Komagata T, Obara H.
Journal of Obstetrics and Gynecology. 2020.
https://doi.org/10.1111/jog.14377
(2020/8/7)
Computed tomography surveillance helps tracking COVID-19 outbreak.
Machitori A, Noguchi T, Kawata Y, Horioka N, Nishie A, Kakihara D, Ishigami K, Aoki S, Imai Y.
Jpn J Radiol. 2020.
https://doi.org/10.1007/s11604-020-01026-z
(2020/8/7)
When should clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing targeting patients with pulmonary CT findings suggestive of COVID-19.
Yamamoto K, Saito S, Hayakawa K, Hashimoto M, Takasaki J, Ohmagari N.
Jpn J Infect Dis. 2020.
https://doi.org/10.7883/yoken.JJID.2020.531
(2020/8/3)
▼Published in July 2020
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.
Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N, Sugiyama H.
Crit Care Explor. 2020;2(8):e0170.
https://doi.org/10.1097/CCE.0000000000000170
(2020/7/31)
Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study.
Morioka S, Nakamura K, Iida S, Kutsuna S, Kinoshita N, Suzuki T, Suzuki T, Yamamoto K, Hayakawa K, Saito S, Ohmagari N.
Infection Prevention in Practice. 2020:100079.
https://doi.org/10.1016/j.infpip.2020.100079
(2020/7/30)
Detection of SARS-CoV-2 in hemodialysis effluent of patient with COVID-19 pneumonia, Japan.
Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T, Ohmagari N, Hinoshita F.
Emerg Infect Dis. 2020;26(11):2758-2761.
https://doi.org/10.3201/eid2611.201956
(2020/7/30)
FDG-PET/CT images of COVID-19: a comprehensive review.
Minamimoto R, Hotta M, Ishikane M, Inagaki T.
Glob Health Med. 2020.
https://doi.org/10.35772/ghm.2020.01056
(2020/7/20)
An Experience of PET/CT Examination in the Patient with a Recent History of COVID-19 Infection.
Saito K, Horikawa D, Takeuchi T, Mizunuma H, Yamada Y, Hironaka S, Kajiwara H, Hotta M, Matsunaga F, Minamimoto R.
Japanese Journal of Radiological Technology. 2020;76(7):761-767. Japanese.
https://doi.org/10.6009/jjrt.2020_JJRT_76.7.761
(2020/7/20)
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1I/D genotype.
Yamamoto N, Ariumi Y, Nishida N, Yamamoto R, Bauer G, Gojobori T, Shimotohno K, Mizokami M.
Gene. 2020.
https://doi.org/10.1016/j.gene.2020.144944
(2020/7/3)
A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.
Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y, Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M, Sugiyama H.
Infectious Diseases. 2020;52(10):755-758.
https://doi.org/10.1080/23744235.2020.1784999
(2020/7/2)
▼Published in June 2020
Testing for COVID-19 at travel clinics in Japan.
Ujiie M, Ohmagari N, Inoue H.
J Travel Med. 2020;27(5):taaa107.
https://doi.org/10.1093/jtm/taaa107
(2020/6/27)
COVID-19 can suddenly become severe: a case series from Tokyo, Japan.
Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiy
ama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N.
Glob Health Med. 2020;2(3):174-177.
https://doi.org/10.35772/ghm.2020.01054
(2020/6/27)
SARS-CoV-2 screening test for Japanese returnees from Wuhan, China, January 2020.
Kutsuna S, Suzuki T, Hayakawa K, Tsuzuki S, Asai Y, Suzuki T, Ide S, Nakamura K, Moriyama Y, Kinoshita N, Hosokawa N, Osawa R, Yamamuro R, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Saito S, Ishikane M, Morioka S, Yamamoto K, Ujiie M, Terada M, Nakamura-Uchiyama F, Sahara T, Sano M, Imamura A, Sekiya N, Fukushima K, Kawana A, Fujikura Y, Sano T, Suematsu R, Sakamoto N, Nagata K, Kato T, Katano H, Wakita T, Sugiyama H, Kokudo N, Ohmagari N.
Open Forum Infect Dis. 2020;7(7):ofaa243.
https://doi.org/10.1093/ofid/ofaa243
(2020/6/20)
Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, Fukaya T, Hinoshita F, Ohmagari N.
Blood Purif. 2020.
https://doi.org/10.1159/000508062
(2020/6/11)
A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Yamamoto K, Ohmagari N.
J Med Virol. 2020.
https://doi.org/10.1002/jmv.26102
(2020/6/3)
Cautious handling of urine from moderate to severe COVID-19 patients.
Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M,Sadamasu K, Yoshimura K, Ohmagari N.
Am J Infect Control. 2020;48(8):969-971.
https://doi.org/10.1016/j.ajic.2020.05.034
(2020/6/2)
▼Published in May 2020
Corticosteroid therapy for severe COVID-19 pneumonia: optimal dose and duration of administration.
Matsuda W, Okamoto T, Uemura T, Kobayashi K, Sasaki R, Kimura A.
Glob Health Med. 2020;2(3):193-196.
https://doi.org/10.35772/ghm.2020.01046
(2020/5/30)
A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020.
Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N.
Jpn J Infect Dis. 2020.
https://doi.org/10.7883/yoken.JJID.2020.240
(2020/5/29)
A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan.
Sato R, Ishikane M, Kinoshita N, Suzuki T, Nakamoto T, Hayakawa K, Bekki N, Hara H, Ohmagari N. 
Glob Health Med. 2020;2(2):190-192.
https://doi.org/10.35772/ghm.2020.01044
(2020/5/15)
Rapid health systems change: online medical consultations to fight COVID-19.
Wang H, Song P, Gu Y, Schroeder E, Jin C.
Ann Transl Med. 2020;8(11):726.
https://dx.doi.org/10.21037/atm-20-2618
(2020/5/13)
Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection.
Suzuki T, Kutsuna S, Nakamura K, Ide S, Moriyama Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Hayakawa K, Ohmagari N.
J Infect Chemother. 2020;26(8):851-853.
https://doi.org/10.1016/j.jiac.2020.05.002
(2020/5/8)
▼Published in April 2020
Effect of temperature on the infectivity of COVID-19.
Ujiie M, Tsuzuki S, Ohmagari N.
Int J Infect Dis. 2020;95:301‐303.
https://doi.org/10.1016/j.ijid.2020.04.068
(2020/4/30)
Japanese strategy to COVID-19: How does it work?
Inoue H.
Glob Health Med. 2020;2(2):131-132.
https://doi.org/10.35772/ghm.2020.01043
(2020/4/30)
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital.
Morioka S, Saito S, Hayakawa K, Takasaki Jin, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Ohmagari N.
Psychiatry Res. 2020;289:113040.
https://doi.org/10.1016/j.psychres.2020.113040
(2020/4/29)
Early cases of COVID-19 in Tokyo and occupational health.
Kuwahara K, Hori A, Ohmagari N, Mizoue T.
Glob Health Med. 2020;2(2):118-122.
https://doi.org/10.35772/ghm.2020.01041
(2020/4/29)
Epidemiology and quarantine measures during COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan in2020: a descriptive analysis.
Tsuboi M, Hachiya M, Noda S, Iso H, Umeda T.
Glob Health Med. 2020;2(2):102-106.
https://doi.org/10.35772/ghm.2020.01037
(2020/4/29)
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine.
Hayakawa K, Kutsuna S, Kawamata T, Sugiki Y, Nonaka C, Tanaka K, Shoji M, Nagai M, Tezuka S, Shinya K, Saito H, Harada T, Moriya N, Tsuboi M, Norizuki M,
Sugiura Y, Osanai Y, Sugiyama M, Okuhama A, Kanda K,Wakimoto Y , Ujiie M, Morioka S, Yamamoto K, Kinoshita N, Ishikane M, Saito S, Moriyama Y, Ota M, Nakamura K, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Suzuki T, Miyazato Y, Gu Y, Matsunaga N, Tsuzuki S, Fujitomo Y, Kusama Y, Shichino H, Kaneshige M, Yamanaka J, Saito M, Hojo M, Hashimoto M, Izumi S, Takasaki J, Suzuki M, Sakamoto K, Hiroi Y, Emoto S, Tokuhara M, Kobayashi T, Tomiyama K, Nakamura F, Ohmagari N, Sugiyama H.
Glob Health Med. 2020;2(2):107-111.
https://doi.org/10.35772/ghm.2020.01036
(2020/4/29)
Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan.
Ito K, Ohmagari N, Mikami A, Sugiura W.
Glob Health Med. 2020;2(2):96-101.
https://doi.org/10.35772/ghm.2020.01034
(2020/4/29)
Coronavirus disease 2019 (COVID-19): research progress and clinical practice.
Kutsuna S.
Glob Health Med. 2020;2(2):78-88.
https://doi.org/10.35772/ghm.2020.01031
(2020/4/26)
The National Health Service (NHS) response to the COVID-19 pandemic: a colorectal surgeon’s experience in the UK.
Yano H.
Glob Health Med. 2020;2(2):138-139.
https://doi.org/10.35772/ghm.2020.01035
(2020/4/24)
Challenges to neonatal care in Cambodia amid the COVID-19 pandemic.
Iwamoto A, Tung R, Ota T, Hosokawa S, Matsui M.
Glob Health Med. 2020;2(2):142-144.
https://doi.org/10.35772/ghm.2020.01030
(2020/4/23)
The necessity of continuous international cooperation for establishing the coronavirus disease 2019 diagnostic capacity despite the challenges of fighting the outbreak in home countries.
Nozaki I, Miyano S.
Glob Health Med. 2020;2(2):145-147.
https://doi.org/10.35772/ghm.2020.01023
(2020/4/21)
Sustainable implementation of international health cooperation projects while Japanese technical experts cannot go to low- and middle-income countries because of the COVID-19 pandemic travel restrictions.
Obara H, Noda S, Fujita N, Miyoshi C, Akashi H.
Glob Health Med. 2020;2(2):148-150.
https://doi.org/10.35772/ghm.2020.01029
(2020/4/21)
Can we apply lessons learned from Ebola experience in West Africa for COVID-19 in lower income countries?
Nagai M, Oikawa M, Tamura T, Egami Y, Fujita N.
Glob Health Med. 2020;2(2):140-141.
https://doi.org/10.35772/ghm.2020.01028
(2020/4/19)
Nursing care for patients with COVID-19 on extracorporeal membrane oxygenation (ECMO) support.
Umeda A, Sugiki Y.
Glob Health Med. 2020;2(2):127-130.
https://doi.org/10.35772/ghm.2020.01018
(2020/4/16)
▼Published in March 2020
Analysis of COVID-19 infection spread in Japan based on stochastic transition model.
Karako K, Song P, Chen Y, Tang W.
Biosci Trends. 2020;14(2):134‐138.
https://doi.org/10.5582/bst.2020.01482
(2020/3/19)